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Abstract
Merkel cells (MCs) are involved in mechanoreception, but several lines of evidence suggest that they may also participate in
skin disorders through the release of neuropeptides and hormones. In addition, MC hyperplasias have been reported in
inflammatory skin diseases. However, neither proliferation nor reactions to the epidermal environment have been
demonstrated. We established a culture model enriched in swine MCs to analyze their proliferative capability and to
discover MC survival factors and modulators of MC neuroendocrine properties. In culture, MCs reacted to bFGF by
extending outgrowths. Conversely, neurotrophins failed to induce cell spreading, suggesting that they do not act as a
growth factor for MCs. For the first time, we provide evidence of proliferation in culture through Ki-67 immunoreactivity. We
also found that MCs reacted to histamine or activation of the proton gated/osmoreceptor TRPV4 by releasing vasoactive
intestinal peptide (VIP). Since VIP is involved in many pathophysiological processes, its release suggests a putative
regulatory role for MCs in skin disorders. Moreover, in contrast to mechanotransduction, neuropeptide exocytosis was Ca
2+-
independent, as inhibition of Ca
2+ channels or culture in the absence of Ca
2+ failed to decrease the amount of VIP released.
We conclude that neuropeptide release and neurotransmitter exocytosis may be two distinct pathways that are
differentially regulated.
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Introduction
Merkel cells (MCs) are cutaneous neuroendocrine cells that are
mainly found in touch-sensitive areas of the glabrous epidermis
and outer root sheaths of hair follicles [1,2,3]. MCs are discerned
from keratinocytes by their close connections to sensory neurons,
the presence of dense-core neurosecretory granules and expression
of cytokeratin (CK) 20. Their relationship with nerve terminals
and their particular location have led to the hypothesis that MCs
function in mechanoreception [4]. Furthermore, convincing
evidences have demonstrated their excitability [5], expression of
fundamental proteins of the synaptic machinery [6], synaptic-like
contact with sensory neurons [7,8] and involvement of the Ca
2+-
induced Ca
2+ release (CICR) pathway in the production of Ca
2+
transients [9,10,11].
In addition, MCs produce bioactive amines and peptides such
as serotonin, met-enkephalin, chromogranin A, calcitonin gene-
related peptide (CGRP) and vasoactive intestinal peptide (VIP),
which are held in dense-core granules [12,13]. Thus, they belong
to the neuroendocrine cell family. It is widely accepted that
neuroendocrine cells participate in tissue homeostasis, cell growth
and regeneration. The presence of non-innervated MCs in hair
follicles [14] and in oral mucosa [15] fosters the idea that MCs
assume such functions. Finally, MCs are thought to stimulate
keratinocyte proliferation, to regulate skin homeostasis and the
hair cycle and to play a trophic role toward sensory neurons
[16,17]. Unfortunately, the role of MCs in the cutaneous
environment remains largely unexplored.
MCs appear to be quite scarce in the epidermis, which has
hampered their study in vitro. Analyses performed in total
epidermal cell cultures revealed that they are difficult to maintain
for more than two weeks [18,19]. MCs were not labeled by BrdU
[20], they did not incorporate
3H-thymidine [21] and they were
not immunoreactive to Ki-67 [22,23], an antigen that is associated
with proliferating cells. Thus, in contrast to neighboring
keratinocytes, they apparently do not renew. However, MC
hyperplasias have been reported in some inflammatory skin
diseases [24], such as actinic keratosis [25], neurodermatitis [26]
and fibrous papules [27], which suggests that they proliferate
under certain conditions and that they have a role in skin
disorders.
In the skin, VIP is produced by MCs and some peptidergic
nerve terminals [28,29]. VIP was shown to enhance the
proliferation of keratinocytes [30], to induce mast cell degranu-
lation [31] and to enhance IL-1a, IL-6, IL-8, RANTES and TNF-
a expression by keratinocytes [32] [33]. Conversely, VIP exhibits
immuno-modulatory activity by decreasing the production of pro-
inflammatory cytokines [34,35]. Since VIP expression is upregu-
lated during psoriasis [36], atopic dermatitis [37] (with conflicting
results) and skin disorders like aquadynia [38], better knowledge of
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the understanding of these diseases.
To gain further insights into the neuroendocrine functions of
MCs, we developed cultures enriched in MCs from swine snouts.
This cell type is enriched in the swine snout. Different growth
factors and molecules were compared. We show here that, in the
presence of serum and a low proportion of keratinocytes, MCs
were able to proliferate. In culture, MCs reacted to histamine and
were able to sense tissue acidification and cell swelling through the
transient receptor potential vanilloid (TRPV) type 4 receptor.
These conditions induced the release of VIP. Conversely,
acetylcholine (Ach) inhibited neuropeptide exocytosis. Moreover,
in contrast to the dependence of their mechanotransduction
properties on Ca
2+ signaling, neuropeptide release involved a
(Ca
2+)-independent secretory pathway that was inhibited by Ca
2+.
Results
Enrichment for MCs
MCs are rare neuroendocrine cells of the epidermis. Due to
their rarity, a great challenge to their study is the harvest of a
sufficient number of cells to perform experiments. A significant
advance was achieved by the purification of GFP-positive MCs
from transgenic mice [6,39], but this method remains restrictive
for most laboratories. Here, we used a positive magnetic cell
sorting strategy to enrich for MCs. The swine snout was preferred
to human biopsies for its higher proportion of MCs as
demonstrated by CK20 immunostaining (Figure 1).
An average of 45.7 (613)610
6 dissociated epidermal cells was
obtained per swine snout. We targeted CD56 antigen for the
purpose of cell sorting. It is one of the only extracellular markers
described for human and swine MCs [40,41], although all MCs do
not express it [42]. We routinely obtained ,5.9610
5 cells
(1.5460.15% of the total dissociated cells) in the CD56-positive
fraction, of which MCs accounted for an average of 62% (63.5) as
shown in over 10 experiments employing CK20 immunofluores-
cence and DAPI counterstaining (Figure 2a). In contrast, CK20-
positive cells were rarely observed in the unlabeled fraction. To
confirm this result, collected cells were post-fixed in glutaraldehyde
buffer and observed by electron microscopy. The ultrastructural
analysis confirmed the predominance of small cells with large,
polylobulated nuclei and clear cytoplasm containing dense-core
granules of an average diameter of 100 nm (Figure 3). This
ultrastructure is characteristic of MCs [1,43], which demonstrates
the ability of this method to enrich for MCs.
Merkel cells in culture
Culture of MCs has been reported to be very difficult. Under
previously reported culture conditions, cells underwent apoptosis
within two weeks and no proliferation was observed [7,20].
However, MC hyperplasia has been reported; therefore, MCs can
proliferate in response to specific factors. We exposed cultured
MCs to different media, growth factors and mediators. The
medium was changed every two days. MCs were analyzed after
three days by immunofluorescence. The keratinocyte growth
medium (K-SFM) did not allow MCs to develop cytoplasmic
extensions. Furthermore, this culture method led to a rapid
decrease in the proportion of MCs due to keratinocyte
proliferation. Therefore, DMEM/F12 was used as a basal
medium. The addition of EGF (20 ng/mL) also failed to affect
MCs, as they remained round in shape. This result was consistent
with their neural crest origin [44]. However, none of NGF
(100 ng/mL), NT-3 (25 ng/mL), BDNF (25 ng/mL) or all three
together modified MC behavior (Figure 2b). Similarly, MCs were
not affected by RA (0.5 mM).
MC hyperplasia occurs in some inflammatory diseases, but
culture with IL-6 or TNF-a did not lead to MC proliferation [7].
Hence, we cultured MCs with glucocorticoid (Dexa, 1 mM) to
evoke growth arrest and differentiation with the aim of observing
cell spreading. However, Dexa did not induce extension of
cytoplasmic outgrowths. By contrast, once stimulated by bFGF
(20 ng/mL), MCs clearly developed cytoplasmic processes and
became easily distinguishable from keratinocytes (Figure 2c).
These morphological changes reflected the viability of the cells
and indicated that bFGF is a likely survival factor for MCs.
Merkel cells can proliferate in vitro
Finally, we cultured MCs in DMEM/F12 serum-supplemented
medium (7% FCS and 7% HS). After three days, most of the cells
assumed a dendritic shape more readily than with bFGF. In this
condition, MCs established numerous connections between one
another, and several stacks of dendritic MCs were observed
(Figure 4a, b). This particular configuration was confirmed by
immunofluorescence against CK20 (Figure 4c). Strikingly, this
particular arrangement evoked the configuration that MCs
physiologically take in areas sensitive to touch, like in the footpads
of rodents, as we found by immunohistochemistry of dissociated
epidermal layers (Figure 4d).
Therefore, we addressed the question of how such arrangements
develop. Specific cell migrations were contested and MCs are
thought to be terminally differentiated so they may not proliferate
[7,22,23]. In the present study, we tested the immunoreactivity of
cultured MCs to the proliferation marker Ki-67. Unexpectedly,
many cells were positive for both CK20 and Ki-67.All phases of
mitosis were visible: prophase (Figure 5a), metaphase (Figure 5b),
anaphase (Figure 5c, e) and telophase (Figure 5d, e). MCs were
followed for over four weeks in culture, but proliferating CK20-
positive cells were detected only during the first two weeks after
enrichment. These results demonstrate for the first time that MCs
can undergo mitosis in vitro. We supposed that keratinocyte
factors disable this capability, which would explain why previous
reports failed to amplify MCs.
MCs produce VIP in culture
MCs of most mammalian species produce VIP [45]. Converse-
ly, keratinocytes do not express it under physiological conditions
[38]. In our culture conditions, MCs were immunoreactive to VIP
Figure 1. MC are densely represented in the swine snout. MCs
labeled by CK20 immunostaining (in red) appear abundant in the basal
layer of the epidermis of swine snout. Conversely, less than 50 MCs/
mm
2 were found in human glabrous skin. Nuclei were stained in blue
with DAPI. (Scale bar, 50 mm).
doi:10.1371/journal.pone.0006528.g001
Merkel Cells
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picture demonstrated that nearly all CK20-positive MCs also
produced VIP, and that cells other than MCs were not found to
express VIP. In addition, the synthesis of VIP was detected by
western blot (WB) analysis of whole cell homogenates produced
from cultures enriched in MCs (Figure 6, WB). In contrast,
calcitonin gene-related peptide (CGRP) and substance P were
produced by MCs and keratinocytes. Neuropeptide Y (NPY) was
hardly detectable in our cultures (data not shown).
Ca
2+ signaling in neuropeptide release from MCs
MCs were shown to express the histamine H3 receptor [46] and
TRPV4 [47], and Ca
2+ signaling was demonstrated to be an
essential component in mechanoreception [9]. We analyzed how
these factors modulate neuropeptide exocytosis from MCs by
monitoring the amount of VIP released into the culture medium
by ELISA. Cells were stimulated in DMEM/F12, which contains
1m MC a
2+, as a control condition. Supernatant was harvested
and analyzed after 5 min. The basal level was defined as 100%.
Activation of TRPV4 by its specific agonist, 4a-phorbol-12,13-
didecanoate (4aPDD) (1 mM), enhanced VIP release by 42%,
while stimulation by histamine (100 mM) led to an increase of 25%
(Figure 7, difference was significant at P#0.025, n=4). Thus,
MCs react to histamine and are able to perceive tissue acidification
and cell swelling through TRPV4.
To study the involvement of Ca
2+ signaling in neuropeptide
release, a 5-min pre-incubation was performed with the Ca
2+
channel inhibitor ruthenium red (RR) (1 mM). Unexpectedly, this
treatment increased the VIP concentration in the supernatant
following histamine (+72%) as well as to 4aPDD (+70%)
stimulation. To confirm this result, we stimulated MCs by
treatment with 4aPDD in Ca
2+-free PBS. In this case, a dramatic
enhancement of VIP release was measured (+131%). These results
strongly suggest that dense-core granule exocytosis occurs via
Ca
2+-independent signaling. Moreover, activation of Ca
2+ signal-
ing seems to interfere with VIP release.
In some neurons and neuroendocrine cells in which both dense-
core granules and synaptic vesicles co-exist, an intracellular
pathway other than Ca
2+ signaling can modulate exocytosis
[48]. This pathway exists in neurons that co-produce Ach as a
neurotransmitter and neuropeptides such as VIP. In such a
configuration, Ach has been reported to inhibit VIP release
through the muscarinic Ach receptor [49,50]. To find out whether
MCs respond like these cells, we stimulated them with Ach.
Addition of Ach (10 mM) to the culture medium reduced the
release of VIP by 23%; however, pre-inhibition of Ca
2+ channels
with RR (1 mM) before Ach stimulation enhanced VIP release by
107% (Figure 7, n=4). These results are consistent with signaling
via the muscarinic Ach receptor.
To explore this phenomenon further, we stimulated MCs in
Ca
2+-free medium (MEME). In this condition, Ach failed to inhibit
VIP release significantly (Figure 8, P.0.1, representative results
from two experiments). The addition of Ca
2+ (1 mM) to the
culture medium was sufficient to reduce this amount to a lower
level (216%), which corroborates the previous results (Figure 7
and 8). Stimulation by Ach in the presence of Ca
2+ markedly
inhibited VIP exocytosis (231%), thereby confirming the
involvement of Ca
2+ signaling in the inhibition of neuropeptide
release.
Discussion
Consistent with their neural crest origin [44], MCs were not
found to renew like keratinocytes [20,21,22]. Thus, they are
believed to have a long life span, similar to neurons. MCs act in
mechanoreception, but their exact role remains to be identified.
They are thought to participate in skin homeostasis through the
release of bioactive molecules, but few reports have focused on the
neuroendocrine properties of MCs. This lack of knowledge is
mainly due to the lack of an experimental model. We developed a
method for generating cultures enriched in porcine MCs. In the
process of this work, we identified in vitro survival factors and
Figure 2. Immunofluorescence on selected Merkel cells in culture. (a) After enrichment, an average of 62% (63.5) MCs was obtained over 10
experiments as demonstrated by immunostaining using anti-CK20 antibodies and DAPI as a counterstain. In order to define a suitable culture
medium for MCs, cells were stimulated by various factors and the morphology of MCs was analyzed by CK20 immunofluorescence. Using DMEM/F12
as a basal medium, neither EGF (20 ng/mL), RA (0.5 mM) or Dexa (1 mM) supported the spreading of MCs. Similarly, neither NGF (100 ng/mL), BDNF
(25 ng/mL), NT-3 (25 ng/mL) or the three factors together (b) stimulated the growth of cytoplasmic extensions. (c) Conversely, MCs reacted to bFGF
(20 ng/mL), as they extended cytoplasmic outgrowths (arrows), suggesting that this factor acts as a growth factor for MCs. (Scale bar in all pictures,
50 mm).
doi:10.1371/journal.pone.0006528.g002
Merkel Cells
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Subsequently, we found that the MCs reacted to histamine and
activation of TRPV4. These stimulations led to VIP release in a
Ca
2+-independent manner. Conversely, Ach inhibited VIP release,
probably through the activation of Ca
2+ channels.
Previous attempts to culture MCs were performed in total
epidermal cell cultures in which keratinocytes were predominant.
In these cultures, MCs were difficult to maintain for more than
two weeks, they did not undergo mitosis and the low number of
MCs restricted the opportunities for analysis [7,18,51]. To
overcome these obstacles, E. A. Lumpkin and her team used
transgenic mice from which GFP-positive MCs were efficiently
selected by fluorescence-activated cell sorting (FACS) [6]. Here,
we used a magnetic cell sorting system to select MCs from swine
snout, as this tissue has one of the highest densities of MCs among
mammalian tissues (Figure 1). Compared to FACS selection, we
achieved a lower ratio of MCs in our cultures (60–65% versus 85–
95%), but a higher number of MCs per animal. In addition, this
technique has been successfully used to enrich human MCs, but
with a yield proportional to the lower initial MC density in this
tissue.
Through morphological analysis by fluorescence microscopy,
we observed MC spreading in the presence of bFGF. The
extension of outgrowths reflected the activity of a growth factor.
This finding suggests involvement of the bFGF pathway in MC
hyperplasia and possibly in Merkel cell carcinoma (MCC). By
contrast, keratinocyte growth factors did not stimulate the
development of MC extensions. This finding could be consistent
with their neural crest origin; however, all of the tested
neurotrophins failed to support the development of cytoplasmic
extensions (Figure 2b). This result is surprising given that the nerve
dependency of MCs in vivo has been reported several times. First,
mice lacking receptors for NGF, BDNF and NT-3 (TrkA, TrkB
and TrkC respectively) have a lower number of MCs than control
mice [52,53]. Also, NT-3 appears not to be essential for the
development of MCs, but its absence leads to perinatal apoptosis
of MCs [54]. Finally, overexpression of NT-3 and BDNF
increased the number of MCs [55,56]. In fact, all these mutations
also affect the cutaneous nerve density, which correlates with MC
number. Our in vitro results seem to demonstrate that neurotro-
phins alone are not sufficient to maintain MCs in culture. Hence,
other paracrine factors from sensory nerve endings probably
assume this function.
When cultured in serum-supplemented medium, alignment of
MCs was observed (Figure 4a, b). To the best of our knowledge,
this configuration has not been reported before. Interestingly, in
vitro staking of MCs can be compared to the in vivo staking of
MCs detected in rodent touch pads (Figure 4d), and perhaps they
imply the same events. The proliferative ability of MCs has been a
matter of debate for decades. Based on Ki-67 immunoreactivity,
we provide direct evidence that MCs can undergo mitosis in vitro
(Figure 5), although most studies have concluded that they are
terminally differentiated. We hypothesize that the predominance
of epidermal factors regulates this capability, as suggested by our
results (see above). Thus, an environment rich in MC growth
factors, as occurs in MC hyperplasia, could support the
proliferation of MCs. In our model, MCs underwent mitosis
during the first two weeks, before overgrowth by keratinocytes.
Further analysis of the signaling pathway that initiates primary
MC mitosis would be of interest in the study of MCC. The
recently identified MC polyomavirus [57] integrated in most
MCCs probably interferes with this pathway.
We demonstrated here that MCs react to histamine and to
TRPV4 stimulation by releasing VIP (Figure 7). Thus, in the skin,
MCs would be able to respond to mast cell degranulation, cell
swelling and tissue acidification. Since VIP released in the
epidermal environment is known to have immuno-modulatory
Figure 3. Electron microscopy analysis confirmed the identity
of Merkel cells. Ultrastructural analyses were carried out on cells from
the enriched MC fraction. (a, b) Up to half of the cells presented features
characteristic of MCs: a polylobulated nucleus with numerous typical
dense-core granules in a clear cytoplasm. (c) The thin membrane
distinguishable around the darkest cytoplasmic granules is consistent
with neuroendocrine cells. (Scale bar in a, 5 mm; in b, 2 mm; in c,
500 nm).
doi:10.1371/journal.pone.0006528.g003
Merkel Cells
PLoS ONE | www.plosone.org 4 August 2009 | Volume 4 | Issue 8 | e6528Figure 4. MCs developed cytoplasmic processes when cultured in the presence of serum. Strikingly, in these culture conditions, stacking
of more than five MCs was observed (a, b) and confirmed by CK20 immunofluorescence (c). Interestingly, this stacking is similar to configurations
observed in mechanosensitive areas in the touch pads of rats, as demonstrated by CK20 immunostaining in dissociated epidermal layers (d). The
meaning of these alignments to the role of MCs remains to be defined. (Scale bars, 10 mm).
doi:10.1371/journal.pone.0006528.g004
Figure 5. Merkel cells proliferated in culture. Double immunofluorescence assay using antibodies against CK20 (red) and Ki-67 antigen (green)
revealed the ability of MCs to proliferate in vitro. Dividing CK20-positive cells were clearly visible, and all phases of the cell cycle were observed:
prophase (a), metaphase (b), anaphase (c, e) and telophase (d, e). (Scale bars, 20 mm).
doi:10.1371/journal.pone.0006528.g005
Merkel Cells
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regulatory role of MCs in skin diseases. VIP differentially regulates
immune functions according to the tissue and the disease, and its
role in skin disorders has yet to be detailed. To our knowledge,
these data are the first to support a participatory role of MCs in
skin pathophysiology.
The level of released VIP was lower for cells cultured in
DMEM:F12 (Ca
2+, 1 mM) compared to those cultured in PBS
without Ca
2+ (Figure 7). In order to avoid interactions with
components of the culture medium that are not present in PBS, we
compared the amounts of VIP released in MEME (a medium
without Ca
2+) with or without the addition of Ca
2+ (Figure 8), and
we found similar results. These data contrast with the Ca
2+-
dependence of the synaptic vesicle exocytosis underlying mechan-
otransduction. Thus, two distinct secretory pathways are indicat-
Figure 6. Merkel cells produced VIP in culture. In our culture conditions, MCs produced the neuropeptide VIP as demonstrated by double
immunofluorescence using antibodies against CK20 (red) and VIP (green). The production of VIP was confirmed by western blot analysis (WB). (Scale
bar, 50 mm).
doi:10.1371/journal.pone.0006528.g006
Figure 7. Percentage of VIP released by Merkel cells. The
amount of VIP released in the culture supernatant, assessed by ELISA
and expressed as a percentage of the control conditions (DMEM/F12
containing 1 mM Ca
2+). Exposure to the TRPV4 agonist 4aPDD (1 mM)
or histamine (100 mM) stimulated VIP release from MCs. This release was
not inhibited by pre-incubation with the Ca
2+ channel inhibitor RR
(1 mM), indicating a Ca
2+-independent pathway. The marked increase of
VIP release obtained following stimulation by 4aPDD in a Ca
2+-free
buffer confirmed these results. In addition, exposure to the neuro-
transmitter Ach (10 mM) significantly inhibited the amount of VIP
released in the presence of Ca
2+. This inhibition was suppressed by pre-
incubation with RR (1 mM), suggesting the involvement of Ca
2+
channels (n=4, difference significant at P#0.025.).
doi:10.1371/journal.pone.0006528.g007
Figure 8. Ca
2+ and Ach decreased the release of VIP. Effect of
Ach and Ca
2+ on VIP release expressed in ng/well. MCs were cultured in
Ca
2+-free MEME and then exposed to Ach (100 mM), Ca
2+ (1 mM), or
both. In the absence of Ca
2+, the addition of Ach failed to significantly
decrease VIP exocytosis (P.0.1). A lower amount of VIP release was
observed in the presence of Ca
2+ (1 mM). Finally, the inhibitory effect of
Ach on VIP release required extracellular Ca
2+ (P#0.025). These results
are consistent with inhibition via Ca
2+ channels, probably via muscarinic
M2 or M4 Ach receptors.
doi:10.1371/journal.pone.0006528.g008
Merkel Cells
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2+-dependent signaling pathway activates the CICR
pathway, which leads to neurotransmitter release in the mechan-
otransduction process [9,10,11]. Second, a Ca
2+-independent
pathway is involved in dense-core granule exocytosis. Our data
support the hypothesis that activation of Ca
2+-dependent signaling
inhibits the Ca
2+-independent pathway involved in neuropeptide
release, since inhibition of the first one increased the level of
activation of the second one.
In neurons and neuroendocrine cells where two secretory
pathway co-exist, exocytosis could be regulated or modulated by
intracellular signals such as cAMP or diacylglycerol [49]. This
pathway remains to be clarified for neuropeptide release from
MCs. Furthermore, Consistent with previous studies that have
described interference between Ach exocytosis as a neurotrans-
mitter and VIP release [50], we demonstrated in MCs that Ach
inhibits VIP release in a Ca
2+-dependent manner, probably
through M2 or M4 muscarinic Ach autoreceptors [49]. Based on
these results, we propose Ach as a putative neurotransmitter for
sensory nerve endings, since met-enkephalin and glutamate did
not satisfy this function [58,59].
In conclusion, this work describes a new way to culture of MCs.
In our experimental model, we provide evidence that MCs can
undergo mitosis. Through the release of VIP following histamine
stimulation and activation of TRPV4, MCs probably act in skin
pathophysiology, but their exact role remains to be defined. The
proliferation of MCs in particular conditions could amplify these
effects. In addition, the mechanotransduction properties of MCs
appear to be independent of neuropeptide exocytosis, as the latter
does not require Ca
2+ signaling. Finally, we characterized the role
of Ach in neurosecretory release.
Materials and Methods
Cell cultures enriched in Merkel cells
Swine snouts were retrieved from the local slaughterhouse. Only
young swine aged 2–6 days were used. The epidermal layer was
separated from the dermis by enzymatic digestion with dispase
(15 U/mL, 37uC; Gibco, Paisley, UK). Epidermal cells were
dissociated by digestion with 0.05% trypsin-EDTA (Lonza,
Walkersville, MD). Retrieved cells were passed through a 30-mm
mesh nylon filter, washed twice in chilled phosphate-buffered
saline (PBS) supplemented with 2 mM EDTA and 0.5% fetal
bovine serum (FBS; PAA Laboratories, Pasching, Austria), and
then immunolabeled using microbead-conjugated antibody
against CD56. Cells were isolated using the magnetic cell sorting
system Mini-MACS (Miltenyi Biotec, Bergisch Gladbach, Ger-
many). Viable trypan-blue excluding cells were counted by use of a
hemacytometer. Data were expressed as means6standard devia-
tion. The media used in cell cultures were Dulbecco’s Modified
Eagle Medium/Ham’s F-12 (DMEM/F12) (Lonza), keratinocyte-
serum free medium (K-SFM) (Gibco), and Minimum Essential
Medium Eagle (MEME) (Sigma-Aldrich, St Louis, MO). Fetal calf
serum (FCS) and horse serum (HS) were purchased from PAA
Laboratories. Normocin
TM (100 mg/mL) (Invivogen, San Diego,
CA) was added as an antibiotic. Epidermal growth factor (EGF,
20 ng/mL), basic fibroblast growth factor (bFGF, 20 ng/mL),
nerve growth factor (NGF, 100 ng/mL), neurotrophin-3 (NT-3,
25 ng/mL), brain-derived neurotrophic factor (BDNF, 25 ng/
mL), retinoic acid (RA, 0.5 mM), and dexamethasone (Dexa,
1 mM) were obtained from Sigma-Aldrich.
Immunofluorescence
Cells were seeded on sterile Biocoat CultureSlides coated with
laminin and poly-D-lysine (Becton–Dickinson, Heidelberg, Ger-
many) at 5610
4 cells per slide. Cells were fixed in 4%
paraformaldehyde, permeabilized with 0.5% Triton X-100,
saturated in 5% normal goat serum (NGS) in 0.1% Tween-20 in
PBS (PBS-T) and hybridized with primary antibodies overnight at
4uC in PBS-T, 1% NGS. After two washes, cells were hybridized
for two hours with secondary antibodies. Nuclei were stained for
10 minutes with 49,6-diamidino-2-phenylindole dissolved to
100 ng/mL in PBS. The fluorescence analyses were performed
using a BX41 Olympus upright microscope. Pictures were taken
with an Olympus C-5060 digital camera. The following antibodies
were used: mouse monoclonal anti-CK20 (1:100; Progen GmbH,
Heidelberg, Germany), rabbit polyclonal anti-Ki-67 (1:200;
Abcam, Cambridge, UK), goat polyclonal anti-VIP (1:50; Santa
Cruz Biotechnology, Santa Cruz, CA), mouse monoclonal anti-
human CD56 (1:10; Miltenyi Biotech), goat polyclonal anti-mouse
IgG specific for Fab and conjugated to TRITC (1:300; Sigma-
Aldrich), peroxidase-conjugated donkey polyclonal anti-goat
antibody (1:2,000; Santa Cruz), and goat polyclonal anti-rabbit
IgG specific for F(ab’) and conjugated to FITC (1:500; Jackson
ImmunoResearch, West Grove, PA).
Immunohistochemistry
Pieces of skin biopsies were embedded in OCT, cryopreserved
in isopentane chilled on liquid nitrogen and sections with a
thickness of 10 mm were cut. Slides were saturated with 5% NGS
in PBS with 0.05% Triton X-100 for 15 minutes and subsequently
hybridized with primary antibodies. Slides were rinsed twice and
hybridized with appropriate secondary antibodies for two hours at
room temperature. The antibodies used were those described
above.
Electron microscopy
MC-enriched suspensions were fixed in 2.5% glutaraldehyde for
30 minutes, rinsed in 0.1 M cacodylate buffer, and post-fixed for
one hour with 1% OsO4. Cells were dehydrated in graded
concentrations of alcohol, and finally by propylene oxide. Then,
cells were embedded in epoxy resin for one day at 60uC. Finally,
ultrathin sections were cut and observed with a Jeol, Jem-1010
Electron Microscope.
Analysis of neuropeptide release
VIP is produced by MCs of most mammalian species [28]. Its
release was studied by western blot (WB) and ELISA. MCs were
seeded at 5610
4 cells per well in 24-well tissue culture plates for
three days in growth medium. Cells were washed twice and then
exposed to histamine (100 mM), Ach (10 mM), 4 aPDD (1 mM) or
Ca
2+ (1 mM) in DMEM-F12, PBS or MEME with or without
Ca
2+. In some cases, cells were pre-exposed for 5 minutes to the
Ca
2+ channel antagonist ruthenium red (1 mM). All chemicals
were purchased from Sigma-Aldrich. After a 5-minute incubation,
culture supernatants were collected and centrifuged to remove
detached cells. For WB analysis, supernatants were diluted in
Laemmli buffer (100 mM Tris/HCl, 4% SDS, 15% glycerol, 15%
2-mercaptoethanol, 20 mg/mL bromophenol blue). Proteins were
separated by 12% SDS-PAGE and hybridized to nitrocellulose
membranes (PALL). The membranes were proved with the
indicated antibodies. Proteins were detected by chemilumines-
cence using the Western Blotting Luminol Reagent (Santa Cruz).
For ELISA, 50 mL of supernatant were assessed in triplicate in 96-
well ELISA microplates (Greiner Bio One). The wells were
saturated with 3% BSA in PBS-T over-night in order to allow for
complete binding. Hybridizations with primary and secondary
antibodies were carried out for two hours in PBS-T 0.3% BSA.
The amount of neuropeptide was assessed using the SureBlue
Merkel Cells
PLoS ONE | www.plosone.org 7 August 2009 | Volume 4 | Issue 8 | e6528Reserve TMB Microwell Peroxidase substrate (KPL). To measure
the amount of VIP release, the blocking peptide VIP (Santa Cruz)
was used as a standard. A nonparametric Mann-Whitney test was
used for statistical analyses.
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